EWING, N.J.--(BUSINESS WIRE)--Antares Pharma, Inc. (NYSE Amex: AIS) today reported financial and operating results for the third quarter ended September 30, 2011.
Quarter and Recent Highlights
•Achieved record quarterly revenues of $3.9 million for the third quarter and $11.0 million for the year-to-date period. •Increased quarter and year-to-date product revenue 33% and 41%, respectively, compared to the same periods in 2010.
Quarter and Recent Highlights
•Achieved record quarterly revenues of $3.9 million for the third quarter and $11.0 million for the year-to-date period. •Increased quarter and year-to-date product revenue 33% and 41%, respectively, compared to the same periods in 2010.
